Point72 Asset Management, L.P. 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 07:15 am Sale |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
Point72 Asset Management, L.P. | 2,613,453 4.500% |
-572,624 (-17.97%) |
Filing |
| 2023-12-18 4:15 pm Purchase |
2023-12-07 | 13G | Protagonist Therapeutics, Inc. PTGX |
Point72 Asset Management, L.P. | 3,186,077 5.500% |
2,818,071 (+765.77%) |
Filing |
| 2023-02-14 4:11 pm Sale |
2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
Point72 Asset Management, L.P. | 368,006 0.700% |
-2,052,303 (-84.80%) |
Filing |
| 2022-02-14 4:34 pm Sale |
2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
Point72 Asset Management, L.P. | 2,420,309 5.100% |
-1,908,721 (-44.09%) |
Filing |
| 2021-09-21 4:34 pm Purchase |
2021-09-20 | 13G | Protagonist Therapeutics, Inc. PTGX |
Point72 Asset Management, L.P. | 4,329,030 9.100% |
4,329,030 (New Position) |
Filing |